Francesco Draetta

Partner at Omega Funds

View Live Interactive Profile →

Biography

Francesco Draetta is listed under the heading Management on the Omega Funds team page, which prints no individual titles. His title here is taken verbatim from the firm's 17 December 2021 Fund VII announcement, which names him "Francesco Draetta, CFA, CAIA, Partner" and states he was promoted to Partner at that time. The same release states he served on the board of Chord Therapeutics and as Chief Financial Officer of Omega Alpha SPAC (NASDAQ: OMEG). That title is from December 2021 and was not re-confirmed on the current team page, which publishes no titles.

Board Seats

Career Timeline

2021
Announced as promoted to Partner alongside the Fund VII close on 17 December 2021, identified as "Francesco Draetta, CFA, CAIA, Partner"; the release states he served on the board of Chord Therapeutics and as Chief Financial Officer of Omega Alpha SPAC (NASDAQ: OMEG).

Sources & References

Omega Funds - Our Team ↗Omega Funds Closes Oversubscribed $650 Million Fund VII (PR Newswire, 17 December 2021) ↗